KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Enterprise Value (2016 - 2026)

Bausch Health Companies' Enterprise Value history spans 18 years, with the latest figure at -$335.0 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 56.54% to -$335.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$335.0 million, a 56.54% decrease, with the full-year FY2025 number at -$394.0 million, down 61.48% from a year prior.
  • Enterprise Value hit -$335.0 million in Q1 2026 for Bausch Health Companies, up from -$394.0 million in the prior quarter.
  • Over the last five years, Enterprise Value for BHC hit a ceiling of $461.0 million in Q3 2022 and a floor of -$2.4 billion in Q1 2022.
  • Historically, Enterprise Value has averaged -$196.4 million across 5 years, with a median of -$22.0 million in 2023.
  • Biggest five-year swings in Enterprise Value: soared 170.78% in 2022 and later crashed 1009.09% in 2024.
  • Tracing BHC's Enterprise Value over 5 years: stood at $361.0 million in 2022, then tumbled by 106.09% to -$22.0 million in 2023, then crashed by 1009.09% to -$244.0 million in 2024, then plummeted by 61.48% to -$394.0 million in 2025, then grew by 14.97% to -$335.0 million in 2026.
  • Business Quant data shows Enterprise Value for BHC at -$335.0 million in Q1 2026, -$394.0 million in Q4 2025, and -$419.0 million in Q3 2025.